Found 6 matching trials
Phase 1/II, Safety and Immunogenicity Study of AERAS-404 in BCG-Primed Infants PHASE1 Phase I/II, randomized, double-blind, placebo-controlled, safety, immunogen...
Show More Location
PHRU, Chris Hani Baragwanath Hospital
Learn More & Join Trial
A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 Administered in Adults PHASE1 This Phase I study will be conducted as a randomized, double-blind, dose-es...
Show More Location
University of Tampere Vaccine Research Clinic
Learn More & Join Trial
Evaluation of Safety, Immunogenicity, and Prevention of TB With AERAS-404 and BCG Revaccination in Healthy Adolescents PHASE2 Randomized, Placebo Controlled, Partially Blinded Phase II Study to Evaluat...
Show More Location
South African Tuberculosis Vaccine Initiative , Project Office, Brewelskloof Hospital , Harlem Street, Worcester
Learn More & Join Trial
A Study for Safety and Immunogenicity of BCG and AERAS-404 in HIV-Negative, TB-Negative, BCG-Naive Adults PHASE1 70 subjects received BCG intradermally at Study Day -42, then at Study Day ...
Show More Location
Centre Hosptialier Universitaire Vaudois (CHUV)
Learn More & Join Trial
A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 (C-011-404) PHASE1 This Phase I study will be conducted as a randomized, placebo-controlled, d...
Show More Location
South African Tuberculosis Vaccine Institute; Brewelskloof Hospital
Learn More & Join Trial
A Phase I Randomized Placebo-Controlled, Double-Blind Study to Evaluate Safety and Immunogenicity of AERAS-404 Administered as Different Amounts of Antigen and Adjuvant Combinations in HIV-Negative BCG-Vaccinated Adults Without Evidence of Tuberculosis Infection PHASE1 Phase I, randomized, double blinded, Placebo-controlled, immunogenicity and...
Show More Location
Karolinska Institutet, Karolinska University Hospital
Learn More & Join Trial